UB Paderborn / Katalog / Suche / in CDI

1 – 20 von 20

Sortiert nach

Efficacy and safety of ivacaftor in patients with cystic fibrosis who have an Arg117His-CFTR mutation: a double-blind, randomised controlled trial

The lancet respiratory medicine, 2015-07, Vol.3 (7), p.524-533

2015

Volltextzugriff (PDF)

Islet Hormone and Incretin Secretion in Cystic Fibrosis after Four Months of Ivacaftor Therapy

American journal of respiratory and critical care medicine, 2019-02, Vol.199 (3), p.342-351

2019

Volltextzugriff (PDF)

Elevation of 1-Hour Plasma Glucose During Oral Glucose Tolerance Testing Is Associated With Worse Pulmonary Function in Cystic Fibrosis

Diabetes care, 2011-02, Vol.34 (2), p.292-295

2011

Volltextzugriff (PDF)

A Pharmacokinetic Analysis of Tobramycin in Patients Less than Five Years of Age with Cystic Fibrosis: Assessment of Target Attainment with Extended-Interval Dosing through Simulation

Antimicrobial agents and chemotherapy, 2022-05, Vol.66 (5), p.e0237721-e0237721

2022

Volltextzugriff (PDF)

Effect of Sitagliptin on Islet Function in Pancreatic Insufficient Cystic Fibrosis With Abnormal Glucose Tolerance

The journal of clinical endocrinology and metabolism, 2021-09, Vol.106 (9), p.2617-2634

2021

Volltextzugriff (PDF)

Reduced β-Cell Secretory Capacity in Pancreatic-Insufficient, but Not Pancreatic-Sufficient, Cystic Fibrosis Despite Normal Glucose Tolerance

Diabetes (New York, N.Y.), 2017-01, Vol.66 (1), p.134-144

2017

Volltextzugriff (PDF)

Hypoglycemia and Islet Dysfunction Following Oral Glucose Tolerance Testing in Pancreatic-Insufficient Cystic Fibrosis

The journal of clinical endocrinology and metabolism, 2020-10, Vol.105 (10), p.3179-3189

2020

Volltextzugriff (PDF)

Genetic potential and height velocity during childhood and adolescence do not fully account for shorter stature in cystic fibrosis

Pediatric research, 2021-02, Vol.89 (3), p.653-659

2021

Volltextzugriff (PDF)

Elevation of one hour plasma glucose during oral glucose tolerance testing

Pediatric pulmonology, 2015-10, Vol.50 (10), p.963-969

2015

Volltextzugriff (PDF)

Nocturnal saturation and glucose tolerance in children with cystic fibrosis

Thorax, 2011-07, Vol.66 (7), p.574-578

2011

Volltextzugriff (PDF)

Cystic fibrosis as a risk factor for recurrent venous thrombosis at a pediatric tertiary care hospital

The Journal of pediatrics, 2006-05, Vol.148 (5), p.659-664

2006

Volltextzugriff (PDF)

Clinical mechanism of the cystic fibrosis transmembrane conductance regulator potentiator ivacaftor in G551D-mediated cystic fibrosis

American journal of respiratory and critical care medicine, 2014-07, Vol.190 (2), p.175-184

2014

Volltextzugriff (PDF)

Effect of azithromycin on pulmonary function in patients with cystic fibrosis uninfected with Pseudomonas aeruginosa: a randomized controlled trial

JAMA : the journal of the American Medical Association, 2010-05, Vol.303 (17), p.1707

2010

Volltextzugriff (PDF)

A simplified cyclic adenosine monophosphate–mediated sweat rate test for quantitative measure of cystic fibrosis transmembrane regulator (CFTR) function

The Journal of pediatrics, 2000-12, Vol.137 (6), p.849-855

2000

Volltextzugriff (PDF)

Acute flank pain and reversible renal dysfunction associated with nonsteroidal anti-inflammatory drug use

Pediatrics (Evanston), 1993-09, Vol.92 (3), p.459

1993

Volltextzugriff (PDF)

Elexacaftor–Tezacaftor–Ivacaftor for Cystic Fibrosis with a Single Phe508del Allele

The New England journal of medicine, 2019-11, Vol.381 (19), p.1809-1819

2019

Volltextzugriff (PDF)

A CFTR Potentiator in Patients with Cystic Fibrosis and the G551D Mutation

The New England journal of medicine, 2011-11, Vol.365 (18), p.1663-1672

2011

Volltextzugriff (PDF)

Triple Therapy for Cystic Fibrosis Phe508del–Gating and –Residual Function Genotypes

The New England journal of medicine, 2021-08, Vol.385 (9), p.815-825

2021

Volltextzugriff (PDF)

Effect of advanced age on laparoscopic urologic procedures

Journal of endourology, 2007-01, Vol.21 (1), p.62

2007

Volltextzugriff (PDF)

1 – 20 von 20

Suche als RSS-Feed

Aktive Filter

ThemaAdolescent

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(20)
Mit Volltextzugriff
(17)

Publikationsform

Artikel
(20)

Sprache

Englisch
(20)

Erscheinungsjahr

n.n

Thema

Humans
(20)
Female
(18)
Life Sciences & Biomedicine
(18)
Male
(18)
Science & Technology
(18)
Child
(16)
Adult
(14)
Cystic Fibrosis
(13)
Young Adult
(11)
Cystic Fibrosis - Drug Therapy
(9)
Cystic Fibrosis - Physiopathology
(9)
Biological And Medical Sciences
(8)
Cystic Fibrosis Transmembrane Conductance Regulator - Genetics
(8)
Medical Sciences
(8)
Pediatrics
(8)
Cystic Fibrosis - Genetics
(7)
General & Internal Medicine
(7)
Double-Blind Method
(6)
Mutation
(6)

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Efficacy and safety of ivacaftor in patients with cystic fibrosis who have an Arg117His-CFTR mutation: a double-blind, randomised controlled trial

Islet Hormone and Incretin Secretion in Cystic Fibrosis after Four Months of Ivacaftor Therapy

Elevation of 1-Hour Plasma Glucose During Oral Glucose Tolerance Testing Is Associated With Worse Pulmonary Function in Cystic Fibrosis

A Pharmacokinetic Analysis of Tobramycin in Patients Less than Five Years of Age with Cystic Fibrosis: Assessment of Target Attainment with Extended-Interval Dosing through Simulation

Results of a phase IIa study of VX-809, an investigational CFTR corrector compound, in subjects with cystic fibrosis homozygous for the F508del-CFTR mutation

Effect of Sitagliptin on Islet Function in Pancreatic Insufficient Cystic Fibrosis With Abnormal Glucose Tolerance

Reduced β-Cell Secretory Capacity in Pancreatic-Insufficient, but Not Pancreatic-Sufficient, Cystic Fibrosis Despite Normal Glucose Tolerance

Hypoglycemia and Islet Dysfunction Following Oral Glucose Tolerance Testing in Pancreatic-Insufficient Cystic Fibrosis

Genetic potential and height velocity during childhood and adolescence do not fully account for shorter stature in cystic fibrosis

Elevation of one hour plasma glucose during oral glucose tolerance testing

Nocturnal saturation and glucose tolerance in children with cystic fibrosis

Cystic fibrosis as a risk factor for recurrent venous thrombosis at a pediatric tertiary care hospital

Clinical mechanism of the cystic fibrosis transmembrane conductance regulator potentiator ivacaftor in G551D-mediated cystic fibrosis

Effect of azithromycin on pulmonary function in patients with cystic fibrosis uninfected with Pseudomonas aeruginosa: a randomized controlled trial

A simplified cyclic adenosine monophosphate–mediated sweat rate test for quantitative measure of cystic fibrosis transmembrane regulator (CFTR) function

Acute flank pain and reversible renal dysfunction associated with nonsteroidal anti-inflammatory drug use

Elexacaftor–Tezacaftor–Ivacaftor for Cystic Fibrosis with a Single Phe508del Allele

A CFTR Potentiator in Patients with Cystic Fibrosis and the G551D Mutation

Triple Therapy for Cystic Fibrosis Phe508del–Gating and –Residual Function Genotypes

Effect of advanced age on laparoscopic urologic procedures

Aktive Filter

Suchergebnisse filtern